Clinical Trials Logo

Filter by:
NCT ID: NCT03209284 Completed - Clinical trials for Atrophy of Edentulous Maxillary Alveolar Ridge

Influence of Anatomy of Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures

SLSS
Start date: July 15, 2014
Phase:
Study type: Observational

The aim of this study is to analyze neoformed bone after maxillary sinus lifting with transcrestal approach, in atrophic crests (≤5 mm residual bone height). Clinical and laboratory data will be related to maxillo breast anatomy.

NCT ID: NCT03208634 Completed - Chronic Stroke Clinical Trials

Rehabilitation Multi Sensory Room for Robot Assisted Functional Movements in Upper-limb Rehabilitation in Chronic Stroke

RehaMSR
Start date: October 2013
Phase: N/A
Study type: Interventional

Robotic rehabilitation is promising to promote function in stroke patients. The assist as needed training paradigm has shown to stimulate neuroplasticity but often cannot be used because stroke patients are too impaired to actively control the robot against gravity. Aim of this study is to present a novel robotic approach based on fully assisted functional movements and to examine the effect of the intervention in terms of motor function improvement in subjects with chronic stroke in the short term and at 6-month follow up. A preliminary evaluation of the effectiveness of the intervention in improving activity and participation in the short term is also performed. Further, the study aims to verify whether some instrumental measures (using kinematics, EMG and EEG) may help gain insight into the mechanisms leading to improved motor ability following the robotic intervention and can be used to predict functional recovery.

NCT ID: NCT03208270 Completed - Clinical trials for Extracorporeal Membrane Oxygenation

Antithrombin Supplementation in ECMO

Start date: July 28, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Bleeding is the most feared complication during extracorporeal membrane oxygenation (ECMO) and is associated with high dosing of heparin. There is no consensus on antithrombin (AT) supplementation during ECMO. However, AT is needed by heparin to properly anticoagulate. We hypothesize that maintaining normal antithrombin levels during ECMO is associated with a less heparin dosing and more adequate level of anticoagulation.

NCT ID: NCT03207932 Completed - Clinical trials for Success Rate for Subclavian or Femoral Vein Catetherisation

Ultrasound Guidance Versus Anatomical Landmarks for CVC Catheterisation:

Start date: May 10, 2018
Phase:
Study type: Observational [Patient Registry]

anatomical landmarks on the body surface were used to insert central vein catheter. However, ultrasound technique is emerging as a new technique for vein catheterisation. For subclavian and femoral vein catheterisation, up to now, there is a lack of evidence of the superiority of one technique over the other.

NCT ID: NCT03207490 Completed - Stroke Clinical Trials

Robotics for Rehabilitation of Hand and Fingers After Stroke

sERF
Start date: July 2014
Phase: N/A
Study type: Interventional

The major issue for a person who has suffered a stroke is the severe impairment affecting the hand and the high risk to have a poor recovery associated. Innovative approaches are needed in the next future, translating recent advances from neuro-engineering, into feasible devices for rehabilitation care. The FP7-EU project MYOSENS aims to translate known motor control logic from sEMG prosthetic control, to rehabilitation robotics. The target is to promote the closing of sensory-motor loop on the basis of intention to move, as detected from residual sEMG (i.e. Extensor Digitorum Communis, Flexor Digitorum Profundus).

NCT ID: NCT03207009 Completed - Beta-Thalassemia Clinical Trials

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia

Start date: June 8, 2017
Phase: Phase 3
Study type: Interventional

This is a single-arm, multi-site, single-dose, Phase 3 study in approximately 18 participants less than or equal to (<=) 50 years of age with transfusion-dependent β-thalassemia (TDT), who have a β0/β0, β0/IVS-I-110, or IVS-I-110/IVS-I-110 genotype. The study will evaluate the efficacy and safety of autologous hematopoietic stem cell transplantation (HSCT) using LentiGlobin BB305 Drug Product.

NCT ID: NCT03205514 Completed - Myocardial Ischemia Clinical Trials

Multimodality Investigation of Intermediate Culprit Lesion With Negative FFR in NSTE-ACS

SHERLOCK
Start date: June 28, 2017
Phase:
Study type: Observational [Patient Registry]

Ten-fifteen percent of acute coronary syndromes without ST-segment elevation (NSTE-ACS) are caused by intermediate lesions without signs of unstable plaque. In this subset of patients, fractional flow reserve (FFR) has some drawbacks and may not be always able to predict outcome, especially when negative (above 0.80). In this particular nique of patients, advanced imaging techniques are suggested by International guidelines. However, it is actually unknown how these techniques may impact treatment strategies. With the present study, the investigators want to characterize the mechanism of disease in this particular subset of patients through multimodality imaging (intravascular ultrasound-near infrared spectroscopy (IVUS-NIRS), optical coherence tomography (OCT)) in order to understand the proper treatment.

NCT ID: NCT03204864 Completed - HF Patient Clinical Trials

Optimization of Coronary Sinus Lead Placement Targeted to the Longest Right-to-Left Delay

Opsite 2
Start date: March 1, 2016
Phase: N/A
Study type: Interventional

This study is a prospective, multi-center, physician-initiated study, with intra-center control arm of patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT) with or without defibrillator therapy. The purpose of this study is to verify whether optimizing the left ventricular lead position at implantation with the pacing cathode corresponding to the longest RV-to-LV electrical delay may result in a better patient outcome. The RV-to-LV electrical delay will be evaluated with RLD value (ms). RLD is the distance between the Right Ventricular pacing marker (VP) and the maximum peak (or the first maximum peak in case of two equally tall peaks) of the LV bipolar deflection.

NCT ID: NCT03204331 Completed - Clinical trials for Endometriosis Related Pain

SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

Start date: November 1, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the benefit and safety of relugolix 40 milligrams (mg) once daily, co-administered with low-dose estradiol (E2) and norethindrone acetate (NETA) compared with placebo for 24 weeks, on dysmenorrhea and on nonmenstrual pelvic pain.

NCT ID: NCT03203356 Completed - Clinical trials for Growth Hormone Treatment

Adrenal Function in GHD Children

Start date: May 30, 2016
Phase: N/A
Study type: Observational

To evaluate in children affected by idiopathic GHD the adrenal function both at baseline and after 6 and 12 months of GH treatment.